U.S. FTC allows Amgen to move forward with $27.8 bln Horizon deal - CNBC

Horizon Therapeutics

01/09/2023 13:53

Sept 1 (Reuters) - The U.S. Federal Trade Commission has
allowed Amgen Inc  AMGN.O  to move ahead with its $27.8 billion
deal to buy Horizon Therapeutics  HZNP.O , CNBC reported on
Friday. 

 (Reporting by Manas Mishra in Bengaluru)
 ((Manas.Mishra@thomsonreuters.com;
www.twitter.com/Manaswrites15;))